Ravi Kumar
Diabetes
Arkay Therapeutics
India
Biography
Dr. Ravi Kumar has served as the Scientific Director since 2014. His passion for bringing innovative medicine to Type II diabetes patients and the need for innovative drugs that differentiate mechanistically and clinically from the currently marketed drugs are the motivating force behind ARKAY Therapeutics. Dr. Kumar has a unique combination of expertise in metabolic, cardiovascular and chronic inflammatory diseases. Type II diabetes runs in Dr. Kumar's family; he knows first-hand, the challenges of Type II diabetes patients, the limitations of currently marketed drugs and the devastating consequences of diabetes-related complications. He developed the scientific rationale, product concept, methods and clinical strategies for ARKAY's anti-inflammatory beta-cell centric product platform to develop personalized medicines for treating patient specific comorbidities.
Research Interest
diabetes
